NCT05130866 2025-10-07
POPLAR-NF2
Recursion Pharmaceuticals Inc.
Phase 2/3 Terminated
Clinical Trials
5 trialsNCT03095248 2025-04-22
SEL-TH-1601
Children's Hospital Medical Center, Cincinnati
Phase 2 Terminated
NCT01345136 2024-02-13
Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
Jonsson Comprehensive Cancer Center
Phase 2 Terminated
NCT03710564 2023-01-30
MERLIN
Novartis
Phase 3 Terminated
NCT00911248 2019-04-12
PTC299 for Treatment of Neurofibromatosis Type 2
PTC Therapeutics
Phase 2 Terminated